Welcome to Health Care POV | sign in | join

February 2017 - Posts

ADVANCE Perspective: Respiratory Views

FDA Approves Symbicort For Treatment of Asthma in Pediatric Patients
February 3, 2017 11:42 AM by ADVANCE for Respiratory Care & Sleep Medicine
In major news for pediatric asthma patients, AstraZeneca this week announced that the U.S. Food and Drug Administration (FDA) approved SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol 80/4.5 micrograms for the treatment of asthma Read More...
0 comments »     

Search

About this Blog

Keep Me Updated